Global Traumatic Brain Injury Therapeutics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 118774
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Traumatic Brain Injury Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Traumatic Brain Injury Therapeutics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Local TBI accounting for % of the Traumatic Brain Injury Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Acetylcholinesterase Inhibitors segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Traumatic Brain Injury Therapeutics include SFC Fluidics LLC, Banayan Biomarkers Inc., BHR Pharma LLC, Cerora Inc., and ElMindA Ltd., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Traumatic Brain Injury Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Acetylcholinesterase Inhibitors

Erythropoietin

Growth Hormone

Stem Cells

Others

Market segment by Application, can be divided into

Local TBI

Open TBI

Closed TBI

Diffuse TBI

Primary TBI

Others

Market segment by players, this report covers

SFC Fluidics LLC

Banayan Biomarkers Inc.

BHR Pharma LLC

Cerora Inc.

ElMindA Ltd.

Grace Laboratories LLC

KeyNeurotek Pharmaceuticals AG

Luoxis Diagnostics

Neuro Assessment Systems

Neurovive Pharmaceuticals AB

Oxygen Biotherapeutics Inc.

Phlogistix LLC

Neurohealing Pharmaceuticals

Neuren Pharmaceuticals Ltd.

Remedy Pharmaceuticals Inc.

Biodirection Inc.

Brainscope Company Inc.

TEVA Pharmaceutical Industries Ltd.

Vasopharm

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Traumatic Brain Injury Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Traumatic Brain Injury Therapeutics, with revenue, gross margin and global market share of Traumatic Brain Injury Therapeutics from 2019 to 2022.

Chapter 3, the Traumatic Brain Injury Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Traumatic Brain Injury Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Traumatic Brain Injury Therapeutics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Traumatic Brain Injury Therapeutics

1.2 Classification of Traumatic Brain Injury Therapeutics by Type

1.2.1 Overview: Global Traumatic Brain Injury Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Traumatic Brain Injury Therapeutics Revenue Market Share by Type in 2021

1.2.3 Acetylcholinesterase Inhibitors

1.2.4 Erythropoietin

1.2.5 Growth Hormone

1.2.6 Stem Cells

1.2.7 Others

1.3 Global Traumatic Brain Injury Therapeutics Market by Application

1.3.1 Overview: Global Traumatic Brain Injury Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Local TBI

1.3.3 Open TBI

1.3.4 Closed TBI

1.3.5 Diffuse TBI

1.3.6 Primary TBI

1.3.7 Others

1.4 Global Traumatic Brain Injury Therapeutics Market Size & Forecast

1.5 Global Traumatic Brain Injury Therapeutics Market Size and Forecast by Region

1.5.1 Global Traumatic Brain Injury Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Traumatic Brain Injury Therapeutics Market Size by Region, (2017-2022)

1.5.3 North America Traumatic Brain Injury Therapeutics Market Size and Prospect (2017-2028)

1.5.4 Europe Traumatic Brain Injury Therapeutics Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Traumatic Brain Injury Therapeutics Market Size and Prospect (2017-2028)

1.5.6 South America Traumatic Brain Injury Therapeutics Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Traumatic Brain Injury Therapeutics Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Traumatic Brain Injury Therapeutics Market Drivers

1.6.2 Traumatic Brain Injury Therapeutics Market Restraints

1.6.3 Traumatic Brain Injury Therapeutics Trends Analysis

2 Company Profiles

2.1 SFC Fluidics LLC

2.1.1 SFC Fluidics LLC Details

2.1.2 SFC Fluidics LLC Major Business

2.1.3 SFC Fluidics LLC Traumatic Brain Injury Therapeutics Product and Solutions

2.1.4 SFC Fluidics LLC Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 SFC Fluidics LLC Recent Developments and Future Plans

2.2 Banayan Biomarkers Inc.

2.2.1 Banayan Biomarkers Inc. Details

2.2.2 Banayan Biomarkers Inc. Major Business

2.2.3 Banayan Biomarkers Inc. Traumatic Brain Injury Therapeutics Product and Solutions

2.2.4 Banayan Biomarkers Inc. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Banayan Biomarkers Inc. Recent Developments and Future Plans

2.3 BHR Pharma LLC

2.3.1 BHR Pharma LLC Details

2.3.2 BHR Pharma LLC Major Business

2.3.3 BHR Pharma LLC Traumatic Brain Injury Therapeutics Product and Solutions

2.3.4 BHR Pharma LLC Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 BHR Pharma LLC Recent Developments and Future Plans

2.4 Cerora Inc.

2.4.1 Cerora Inc. Details

2.4.2 Cerora Inc. Major Business

2.4.3 Cerora Inc. Traumatic Brain Injury Therapeutics Product and Solutions

2.4.4 Cerora Inc. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Cerora Inc. Recent Developments and Future Plans

2.5 ElMindA Ltd.

2.5.1 ElMindA Ltd. Details

2.5.2 ElMindA Ltd. Major Business

2.5.3 ElMindA Ltd. Traumatic Brain Injury Therapeutics Product and Solutions

2.5.4 ElMindA Ltd. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 ElMindA Ltd. Recent Developments and Future Plans

2.6 Grace Laboratories LLC

2.6.1 Grace Laboratories LLC Details

2.6.2 Grace Laboratories LLC Major Business

2.6.3 Grace Laboratories LLC Traumatic Brain Injury Therapeutics Product and Solutions

2.6.4 Grace Laboratories LLC Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Grace Laboratories LLC Recent Developments and Future Plans

2.7 KeyNeurotek Pharmaceuticals AG

2.7.1 KeyNeurotek Pharmaceuticals AG Details

2.7.2 KeyNeurotek Pharmaceuticals AG Major Business

2.7.3 KeyNeurotek Pharmaceuticals AG Traumatic Brain Injury Therapeutics Product and Solutions

2.7.4 KeyNeurotek Pharmaceuticals AG Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 KeyNeurotek Pharmaceuticals AG Recent Developments and Future Plans

2.8 Luoxis Diagnostics

2.8.1 Luoxis Diagnostics Details

2.8.2 Luoxis Diagnostics Major Business

2.8.3 Luoxis Diagnostics Traumatic Brain Injury Therapeutics Product and Solutions

2.8.4 Luoxis Diagnostics Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Luoxis Diagnostics Recent Developments and Future Plans

2.9 Neuro Assessment Systems

2.9.1 Neuro Assessment Systems Details

2.9.2 Neuro Assessment Systems Major Business

2.9.3 Neuro Assessment Systems Traumatic Brain Injury Therapeutics Product and Solutions

2.9.4 Neuro Assessment Systems Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Neuro Assessment Systems Recent Developments and Future Plans

2.10 Neurovive Pharmaceuticals AB

2.10.1 Neurovive Pharmaceuticals AB Details

2.10.2 Neurovive Pharmaceuticals AB Major Business

2.10.3 Neurovive Pharmaceuticals AB Traumatic Brain Injury Therapeutics Product and Solutions

2.10.4 Neurovive Pharmaceuticals AB Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Neurovive Pharmaceuticals AB Recent Developments and Future Plans

2.11 Oxygen Biotherapeutics Inc.

2.11.1 Oxygen Biotherapeutics Inc. Details

2.11.2 Oxygen Biotherapeutics Inc. Major Business

2.11.3 Oxygen Biotherapeutics Inc. Traumatic Brain Injury Therapeutics Product and Solutions

2.11.4 Oxygen Biotherapeutics Inc. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Oxygen Biotherapeutics Inc. Recent Developments and Future Plans

2.12 Phlogistix LLC

2.12.1 Phlogistix LLC Details

2.12.2 Phlogistix LLC Major Business

2.12.3 Phlogistix LLC Traumatic Brain Injury Therapeutics Product and Solutions

2.12.4 Phlogistix LLC Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Phlogistix LLC Recent Developments and Future Plans

2.13 Neurohealing Pharmaceuticals

2.13.1 Neurohealing Pharmaceuticals Details

2.13.2 Neurohealing Pharmaceuticals Major Business

2.13.3 Neurohealing Pharmaceuticals Traumatic Brain Injury Therapeutics Product and Solutions

2.13.4 Neurohealing Pharmaceuticals Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Neurohealing Pharmaceuticals Recent Developments and Future Plans

2.14 Neuren Pharmaceuticals Ltd.

2.14.1 Neuren Pharmaceuticals Ltd. Details

2.14.2 Neuren Pharmaceuticals Ltd. Major Business

2.14.3 Neuren Pharmaceuticals Ltd. Traumatic Brain Injury Therapeutics Product and Solutions

2.14.4 Neuren Pharmaceuticals Ltd. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Neuren Pharmaceuticals Ltd. Recent Developments and Future Plans

2.15 Remedy Pharmaceuticals Inc.

2.15.1 Remedy Pharmaceuticals Inc. Details

2.15.2 Remedy Pharmaceuticals Inc. Major Business

2.15.3 Remedy Pharmaceuticals Inc. Traumatic Brain Injury Therapeutics Product and Solutions

2.15.4 Remedy Pharmaceuticals Inc. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Remedy Pharmaceuticals Inc. Recent Developments and Future Plans

2.16 Biodirection Inc.

2.16.1 Biodirection Inc. Details

2.16.2 Biodirection Inc. Major Business

2.16.3 Biodirection Inc. Traumatic Brain Injury Therapeutics Product and Solutions

2.16.4 Biodirection Inc. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Biodirection Inc. Recent Developments and Future Plans

2.17 Brainscope Company Inc.

2.17.1 Brainscope Company Inc. Details

2.17.2 Brainscope Company Inc. Major Business

2.17.3 Brainscope Company Inc. Traumatic Brain Injury Therapeutics Product and Solutions

2.17.4 Brainscope Company Inc. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Brainscope Company Inc. Recent Developments and Future Plans

2.18 TEVA Pharmaceutical Industries Ltd.

2.18.1 TEVA Pharmaceutical Industries Ltd. Details

2.18.2 TEVA Pharmaceutical Industries Ltd. Major Business

2.18.3 TEVA Pharmaceutical Industries Ltd. Traumatic Brain Injury Therapeutics Product and Solutions

2.18.4 TEVA Pharmaceutical Industries Ltd. Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 TEVA Pharmaceutical Industries Ltd. Recent Developments and Future Plans

2.19 Vasopharm

2.19.1 Vasopharm Details

2.19.2 Vasopharm Major Business

2.19.3 Vasopharm Traumatic Brain Injury Therapeutics Product and Solutions

2.19.4 Vasopharm Traumatic Brain Injury Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 Vasopharm Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Traumatic Brain Injury Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Traumatic Brain Injury Therapeutics Players Market Share in 2021

3.2.2 Top 10 Traumatic Brain Injury Therapeutics Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Traumatic Brain Injury Therapeutics Players Head Office, Products and Services Provided

3.4 Traumatic Brain Injury Therapeutics Mergers & Acquisitions

3.5 Traumatic Brain Injury Therapeutics New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Traumatic Brain Injury Therapeutics Revenue and Market Share by Type (2017-2022)

4.2 Global Traumatic Brain Injury Therapeutics Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Traumatic Brain Injury Therapeutics Revenue Market Share by Application (2017-2022)

5.2 Global Traumatic Brain Injury Therapeutics Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Traumatic Brain Injury Therapeutics Revenue by Type (2017-2028)

6.2 North America Traumatic Brain Injury Therapeutics Revenue by Application (2017-2028)

6.3 North America Traumatic Brain Injury Therapeutics Market Size by Country

6.3.1 North America Traumatic Brain Injury Therapeutics Revenue by Country (2017-2028)

6.3.2 United States Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

6.3.3 Canada Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

6.3.4 Mexico Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Traumatic Brain Injury Therapeutics Revenue by Type (2017-2028)

7.2 Europe Traumatic Brain Injury Therapeutics Revenue by Application (2017-2028)

7.3 Europe Traumatic Brain Injury Therapeutics Market Size by Country

7.3.1 Europe Traumatic Brain Injury Therapeutics Revenue by Country (2017-2028)

7.3.2 Germany Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

7.3.3 France Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

7.3.5 Russia Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

7.3.6 Italy Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Traumatic Brain Injury Therapeutics Revenue by Type (2017-2028)

8.2 Asia-Pacific Traumatic Brain Injury Therapeutics Revenue by Application (2017-2028)

8.3 Asia-Pacific Traumatic Brain Injury Therapeutics Market Size by Region

8.3.1 Asia-Pacific Traumatic Brain Injury Therapeutics Revenue by Region (2017-2028)

8.3.2 China Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

8.3.3 Japan Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

8.3.4 South Korea Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

8.3.5 India Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

8.3.7 Australia Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Traumatic Brain Injury Therapeutics Revenue by Type (2017-2028)

9.2 South America Traumatic Brain Injury Therapeutics Revenue by Application (2017-2028)

9.3 South America Traumatic Brain Injury Therapeutics Market Size by Country

9.3.1 South America Traumatic Brain Injury Therapeutics Revenue by Country (2017-2028)

9.3.2 Brazil Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

9.3.3 Argentina Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Traumatic Brain Injury Therapeutics Revenue by Type (2017-2028)

10.2 Middle East & Africa Traumatic Brain Injury Therapeutics Revenue by Application (2017-2028)

10.3 Middle East & Africa Traumatic Brain Injury Therapeutics Market Size by Country

10.3.1 Middle East & Africa Traumatic Brain Injury Therapeutics Revenue by Country (2017-2028)

10.3.2 Turkey Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

10.3.4 UAE Traumatic Brain Injury Therapeutics Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Traumatic Brain Injury Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Traumatic Brain Injury Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Traumatic Brain Injury Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Traumatic Brain Injury Therapeutics Revenue (USD Million) by Region (2017-2022)

Table 5. Global Traumatic Brain Injury Therapeutics Revenue Market Share by Region (2023-2028)

Table 6. SFC Fluidics LLC Corporate Information, Head Office, and Major Competitors

Table 7. SFC Fluidics LLC Major Business

Table 8. SFC Fluidics LLC Traumatic Brain Injury Therapeutics Product and Solutions

Table 9. SFC Fluidics LLC Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Banayan Biomarkers Inc. Corporate Information, Head Office, and Major Competitors

Table 11. Banayan Biomarkers Inc. Major Business

Table 12. Banayan Biomarkers Inc. Traumatic Brain Injury Therapeutics Product and Solutions

Table 13. Banayan Biomarkers Inc. Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. BHR Pharma LLC Corporate Information, Head Office, and Major Competitors

Table 15. BHR Pharma LLC Major Business

Table 16. BHR Pharma LLC Traumatic Brain Injury Therapeutics Product and Solutions

Table 17. BHR Pharma LLC Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Cerora Inc. Corporate Information, Head Office, and Major Competitors

Table 19. Cerora Inc. Major Business

Table 20. Cerora Inc. Traumatic Brain Injury Therapeutics Product and Solutions

Table 21. Cerora Inc. Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. ElMindA Ltd. Corporate Information, Head Office, and Major Competitors

Table 23. ElMindA Ltd. Major Business

Table 24. ElMindA Ltd. Traumatic Brain Injury Therapeutics Product and Solutions

Table 25. ElMindA Ltd. Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Grace Laboratories LLC Corporate Information, Head Office, and Major Competitors

Table 27. Grace Laboratories LLC Major Business

Table 28. Grace Laboratories LLC Traumatic Brain Injury Therapeutics Product and Solutions

Table 29. Grace Laboratories LLC Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. KeyNeurotek Pharmaceuticals AG Corporate Information, Head Office, and Major Competitors

Table 31. KeyNeurotek Pharmaceuticals AG Major Business

Table 32. KeyNeurotek Pharmaceuticals AG Traumatic Brain Injury Therapeutics Product and Solutions

Table 33. KeyNeurotek Pharmaceuticals AG Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Luoxis Diagnostics Corporate Information, Head Office, and Major Competitors

Table 35. Luoxis Diagnostics Major Business

Table 36. Luoxis Diagnostics Traumatic Brain Injury Therapeutics Product and Solutions

Table 37. Luoxis Diagnostics Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Neuro Assessment Systems Corporate Information, Head Office, and Major Competitors

Table 39. Neuro Assessment Systems Major Business

Table 40. Neuro Assessment Systems Traumatic Brain Injury Therapeutics Product and Solutions

Table 41. Neuro Assessment Systems Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Neurovive Pharmaceuticals AB Corporate Information, Head Office, and Major Competitors

Table 43. Neurovive Pharmaceuticals AB Major Business

Table 44. Neurovive Pharmaceuticals AB Traumatic Brain Injury Therapeutics Product and Solutions

Table 45. Neurovive Pharmaceuticals AB Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Oxygen Biotherapeutics Inc. Corporate Information, Head Office, and Major Competitors

Table 47. Oxygen Biotherapeutics Inc. Major Business

Table 48. Oxygen Biotherapeutics Inc. Traumatic Brain Injury Therapeutics Product and Solutions

Table 49. Oxygen Biotherapeutics Inc. Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Phlogistix LLC Corporate Information, Head Office, and Major Competitors

Table 51. Phlogistix LLC Major Business

Table 52. Phlogistix LLC Traumatic Brain Injury Therapeutics Product and Solutions

Table 53. Phlogistix LLC Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Neurohealing Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 55. Neurohealing Pharmaceuticals Major Business

Table 56. Neurohealing Pharmaceuticals Traumatic Brain Injury Therapeutics Product and Solutions

Table 57. Neurohealing Pharmaceuticals Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Neuren Pharmaceuticals Ltd. Corporate Information, Head Office, and Major Competitors

Table 59. Neuren Pharmaceuticals Ltd. Major Business

Table 60. Neuren Pharmaceuticals Ltd. Traumatic Brain Injury Therapeutics Product and Solutions

Table 61. Neuren Pharmaceuticals Ltd. Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Remedy Pharmaceuticals Inc. Corporate Information, Head Office, and Major Competitors

Table 63. Remedy Pharmaceuticals Inc. Major Business

Table 64. Remedy Pharmaceuticals Inc. Traumatic Brain Injury Therapeutics Product and Solutions

Table 65. Remedy Pharmaceuticals Inc. Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Biodirection Inc. Corporate Information, Head Office, and Major Competitors

Table 67. Biodirection Inc. Major Business

Table 68. Biodirection Inc. Traumatic Brain Injury Therapeutics Product and Solutions

Table 69. Biodirection Inc. Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Brainscope Company Inc. Corporate Information, Head Office, and Major Competitors

Table 71. Brainscope Company Inc. Major Business

Table 72. Brainscope Company Inc. Traumatic Brain Injury Therapeutics Product and Solutions

Table 73. Brainscope Company Inc. Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. TEVA Pharmaceutical Industries Ltd. Corporate Information, Head Office, and Major Competitors

Table 75. TEVA Pharmaceutical Industries Ltd. Major Business

Table 76. TEVA Pharmaceutical Industries Ltd. Traumatic Brain Injury Therapeutics Product and Solutions

Table 77. TEVA Pharmaceutical Industries Ltd. Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. Vasopharm Corporate Information, Head Office, and Major Competitors

Table 79. Vasopharm Major Business

Table 80. Vasopharm Traumatic Brain Injury Therapeutics Product and Solutions

Table 81. Vasopharm Traumatic Brain Injury Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. Global Traumatic Brain Injury Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 83. Global Traumatic Brain Injury Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 84. Breakdown of Traumatic Brain Injury Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 85. Traumatic Brain Injury Therapeutics Players Head Office, Products and Services Provided

Table 86. Traumatic Brain Injury Therapeutics Mergers & Acquisitions in the Past Five Years

Table 87. Traumatic Brain Injury Therapeutics New Entrants and Expansion Plans

Table 88. Global Traumatic Brain Injury Therapeutics Revenue (USD Million) by Type (2017-2022)

Table 89. Global Traumatic Brain Injury Therapeutics Revenue Share by Type (2017-2022)

Table 90. Global Traumatic Brain Injury Therapeutics Revenue Forecast by Type (2023-2028)

Table 91. Global Traumatic Brain Injury Therapeutics Revenue by Application (2017-2022)

Table 92. Global Traumatic Brain Injury Therapeutics Revenue Forecast by Application (2023-2028)

Table 93. North America Traumatic Brain Injury Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 94. North America Traumatic Brain Injury Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 95. North America Traumatic Brain Injury Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 96. North America Traumatic Brain Injury Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 97. North America Traumatic Brain Injury Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 98. North America Traumatic Brain Injury Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 99. Europe Traumatic Brain Injury Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 100. Europe Traumatic Brain Injury Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 101. Europe Traumatic Brain Injury Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 102. Europe Traumatic Brain Injury Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 103. Europe Traumatic Brain Injury Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 104. Europe Traumatic Brain Injury Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 105. Asia-Pacific Traumatic Brain Injury Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 106. Asia-Pacific Traumatic Brain Injury Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 107. Asia-Pacific Traumatic Brain Injury Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 108. Asia-Pacific Traumatic Brain Injury Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 109. Asia-Pacific Traumatic Brain Injury Therapeutics Revenue by Region (2017-2022) & (USD Million)

Table 110. Asia-Pacific Traumatic Brain Injury Therapeutics Revenue by Region (2023-2028) & (USD Million)

Table 111. South America Traumatic Brain Injury Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 112. South America Traumatic Brain Injury Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 113. South America Traumatic Brain Injury Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 114. South America Traumatic Brain Injury Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 115. South America Traumatic Brain Injury Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 116. South America Traumatic Brain Injury Therapeutics Revenue by Country (2023-2028) & (USD Million)

Table 117. Middle East & Africa Traumatic Brain Injury Therapeutics Revenue by Type (2017-2022) & (USD Million)

Table 118. Middle East & Africa Traumatic Brain Injury Therapeutics Revenue by Type (2023-2028) & (USD Million)

Table 119. Middle East & Africa Traumatic Brain Injury Therapeutics Revenue by Application (2017-2022) & (USD Million)

Table 120. Middle East & Africa Traumatic Brain Injury Therapeutics Revenue by Application (2023-2028) & (USD Million)

Table 121. Middle East & Africa Traumatic Brain Injury Therapeutics Revenue by Country (2017-2022) & (USD Million)

Table 122. Middle East & Africa Traumatic Brain Injury Therapeutics Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Traumatic Brain Injury Therapeutics Picture

Figure 2. Global Traumatic Brain Injury Therapeutics Revenue Market Share by Type in 2021

Figure 3. Acetylcholinesterase Inhibitors

Figure 4. Erythropoietin

Figure 5. Growth Hormone

Figure 6. Stem Cells

Figure 7. Others

Figure 8. Traumatic Brain Injury Therapeutics Revenue Market Share by Application in 2021

Figure 9. Local TBI Picture

Figure 10. Open TBI Picture

Figure 11. Closed TBI Picture

Figure 12. Diffuse TBI Picture

Figure 13. Primary TBI Picture

Figure 14. Others Picture

Figure 15. Global Traumatic Brain Injury Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 16. Global Traumatic Brain Injury Therapeutics Revenue and Forecast (2017-2028) & (USD Million)

Figure 17. Global Traumatic Brain Injury Therapeutics Revenue Market Share by Region (2017-2028)

Figure 18. Global Traumatic Brain Injury Therapeutics Revenue Market Share by Region in 2021

Figure 19. North America Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Europe Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Asia-Pacific Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. South America Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Middle East and Africa Traumatic Brain Injury Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. Traumatic Brain Injury Therapeutics Market Drivers

Figure 25. Traumatic Brain Injury Therapeutics Market Restraints

Figure 26. Traumatic Brain Injury Therapeutics Market Trends

Figure 27. SFC Fluidics LLC Recent Developments and Future Plans

Figure 28. Banayan Biomarkers Inc. Recent Developments and Future Plans

Figure 29. BHR Pharma LLC Recent Developments and Future Plans

Figure 30. Cerora Inc. Recent Developments and Future Plans

Figure 31. ElMindA Ltd. Recent Developments and Future Plans

Figure 32. Grace Laboratories LLC Recent Developments and Future Plans

Figure 33. KeyNeurotek Pharmaceuticals AG Recent Developments and Future Plans

Figure 34. Luoxis Diagnostics Recent Developments and Future Plans

Figure 35. Neuro Assessment Systems Recent Developments and Future Plans

Figure 36. Neurovive Pharmaceuticals AB Recent Developments and Future Plans

Figure 37. Oxygen Biotherapeutics Inc. Recent Developments and Future Plans

Figure 38. Phlogistix LLC Recent Developments and Future Plans

Figure 39. Neurohealing Pharmaceuticals Recent Developments and Future Plans

Figure 40. Neuren Pharmaceuticals Ltd. Recent Developments and Future Plans

Figure 41. Remedy Pharmaceuticals Inc. Recent Developments and Future Plans

Figure 42. Biodirection Inc. Recent Developments and Future Plans

Figure 43. Brainscope Company Inc. Recent Developments and Future Plans

Figure 44. TEVA Pharmaceutical Industries Ltd. Recent Developments and Future Plans

Figure 45. Vasopharm Recent Developments and Future Plans

Figure 46. Global Traumatic Brain Injury Therapeutics Revenue Share by Players in 2021

Figure 47. Traumatic Brain Injury Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 48. Global Top 3 Players Traumatic Brain Injury Therapeutics Revenue Market Share in 2021

Figure 49. Global Top 10 Players Traumatic Brain Injury Therapeutics Revenue Market Share in 2021

Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 51. Global Traumatic Brain Injury Therapeutics Revenue Share by Type in 2021

Figure 52. Global Traumatic Brain Injury Therapeutics Market Share Forecast by Type (2023-2028)

Figure 53. Global Traumatic Brain Injury Therapeutics Revenue Share by Application in 2021

Figure 54. Global Traumatic Brain Injury Therapeutics Market Share Forecast by Application (2023-2028)

Figure 55. North America Traumatic Brain Injury Therapeutics Sales Market Share by Type (2017-2028)

Figure 56. North America Traumatic Brain Injury Therapeutics Sales Market Share by Application (2017-2028)

Figure 57. North America Traumatic Brain Injury Therapeutics Revenue Market Share by Country (2017-2028)

Figure 58. United States Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Canada Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Mexico Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Europe Traumatic Brain Injury Therapeutics Sales Market Share by Type (2017-2028)

Figure 62. Europe Traumatic Brain Injury Therapeutics Sales Market Share by Application (2017-2028)

Figure 63. Europe Traumatic Brain Injury Therapeutics Revenue Market Share by Country (2017-2028)

Figure 64. Germany Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. France Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. United Kingdom Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Russia Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Italy Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Asia-Pacific Traumatic Brain Injury Therapeutics Sales Market Share by Type (2017-2028)

Figure 70. Asia-Pacific Traumatic Brain Injury Therapeutics Sales Market Share by Application (2017-2028)

Figure 71. Asia-Pacific Traumatic Brain Injury Therapeutics Revenue Market Share by Region (2017-2028)

Figure 72. China Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Japan Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. South Korea Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. India Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Southeast Asia Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Australia Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. South America Traumatic Brain Injury Therapeutics Sales Market Share by Type (2017-2028)

Figure 79. South America Traumatic Brain Injury Therapeutics Sales Market Share by Application (2017-2028)

Figure 80. South America Traumatic Brain Injury Therapeutics Revenue Market Share by Country (2017-2028)

Figure 81. Brazil Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Argentina Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. Middle East and Africa Traumatic Brain Injury Therapeutics Sales Market Share by Type (2017-2028)

Figure 84. Middle East and Africa Traumatic Brain Injury Therapeutics Sales Market Share by Application (2017-2028)

Figure 85. Middle East and Africa Traumatic Brain Injury Therapeutics Revenue Market Share by Country (2017-2028)

Figure 86. Turkey Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 87. Saudi Arabia Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 88. UAE Traumatic Brain Injury Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 89. Methodology

Figure 90. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz